Streetbeat News

RKDA

Arcadia Biosciences, Inc.

https://www.arcadiabio.com

Industry

Agricultural Inputs

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.

Open

3.83

Mkt cap

4M

Volume

59K

High

4.14

P/E Ratio

-0.47

52-wk high

5.34

Low

2.80

Div yield

N/A

52-wk low

1.85

Arcadia Biosciences (RKDA) reported a Q3 loss of $0.87 per share, which was larger than the Zacks Consensus Estimate of a $0.77 loss. However, the company topped revenue estimates.

Portfolio Pulse from

November 13, 2024 | 1:30 am

Arcadia Biosciences, Inc. held its Q3 2024 earnings call, discussing financial results and business highlights. Key participants included CFO Mark Kawakami and CEO T.J. Schaefer.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

HC Wainwright & Co. has reiterated its Buy rating on Arcadia Biosciences (NASDAQ:RKDA) and maintained a price target of $6, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:43 pm

Arcadia Biosciences shares are trading lower following a Q2 EPS miss.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 2:36 pm

Arcadia Biosciences (NASDAQ:RKDA) reported Q2 2024 earnings per share (EPS) of $0.78, missing the analyst consensus estimate of $1.55 by 49.68%. However, the company reported quarterly sales of $1.306 million, beating the analyst consensus estimate of $925,000 by 41.19%. This represents a 0.69% increase over sales of $1.297 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:17 pm

HC Wainwright & Co. has maintained a Buy rating on Arcadia Biosciences (NASDAQ:RKDA) but lowered the price target from $10 to $6.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:15 am

Arcadia Biosciences shares are trading higher following the announcement of the sale of its GoodWheat brand.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:27 pm

Arcadia Biosciences (RKDA) has announced the sale of its GoodWheatTM brand to Above Food Corp for $4 million. This transaction involves the transfer of better-for-you wheat products from Arcadia to Above Food.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:05 pm

Arcadia Biosciences' shares surged following the announcement of the sale of its non-GMO Resistant Starch Durum Wheat trait. This strategic move could potentially streamline the company's operations and focus on its core strengths.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 7:41 pm

Arcadia Biosciences sells its non-GMO Resistant Starch Durum Wheat trait to Corteva Agriscience for $4M, retaining rights for its GoodWheat portfolio use. The deal includes 24 patents in 20 countries, advancing Arcadia's wheat technology monetization.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 12:08 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.